| Full Name | Irfan Admani |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 28 Years |
| Location | 103 River Road, Edgewater, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043228588 | NPI | - | NPPES |
| 3K4611 | Other | NJ | HEALTHNET |
| 02810057 | Medicaid | NY | |
| 2771801000 | Other | NJ | AMERIHEALTH# |
| 7616451 | Other | NJ | AETNA PPO # |
| 719P01 | Other | NJ | EMPIRE BCBS EDGEWATER# |
| 789P01 | Other | NJ | EMPIRE BCBS# SECAUCUS |
| P00336977 | Other | NJ | RAILROAD MEDICARE ID# |
| 1369767 | Other | NJ | AETNA HMO # |
| 8440905 | Medicaid | NJ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 25MA07010400 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hackensack University Medical Center | Hackensack, NJ | Hospital |
| New Bridge Medical Center | Paramus, NJ | Hospital |
| Holy Name Medical Center | Teaneck, NJ | Hospital |
| Entity Name | Hackensack Meridian Health Medical Group - Specialty Care Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215989249 PECOS PAC ID: 9133032519 Enrollment ID: O20031111000524 |
News Archive
Advances in medical technology are a main factor driving the trend of increasing health care costs, and industry stakeholders agree that improved evaluation methods are needed to better measure the benefits and risks of new technologies and procedures in order to avoid misallocation of health care dollars.
Starpharma today announced that it has received final written agreement from the FDA on the design of its Phase 3 clinical studies of VivaGel® for the treatment of bacterial vaginosis (BV) under the FDA's Special Protocol Assessment (SPA) scheme.
Avillion LLP, a co-developer of late-stage pharmaceutical assets, announces the completion of enrolment in a global Phase III clinical trial called "BFORE," which is designed to assess the effectiveness and safety of BOSULIF (bosutinib) as a first-line treatment for patients with chronic phase Philadelphia chromosome positive (Ph+) chronic myelogenous leukemia (CML).
Digitalization is moving forward fast in every field, including medicine. But how can digital tools be integrated into healthcare processes, and how should data be visualized to personalize patient care?
Quest Diagnostics, the world's leading provider of diagnostic information services, today announced that it has signed a definitive agreement to sell its HemoCue diagnostic products business to Radiometer Medical ApS for a purchase price of approximately $300 million plus customary adjustments for cash balances.
› Verified 8 days ago
| Entity Name | Cross County Cardiology P A |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215974118 PECOS PAC ID: 4183652746 Enrollment ID: O20050803001067 |
News Archive
Advances in medical technology are a main factor driving the trend of increasing health care costs, and industry stakeholders agree that improved evaluation methods are needed to better measure the benefits and risks of new technologies and procedures in order to avoid misallocation of health care dollars.
Starpharma today announced that it has received final written agreement from the FDA on the design of its Phase 3 clinical studies of VivaGel® for the treatment of bacterial vaginosis (BV) under the FDA's Special Protocol Assessment (SPA) scheme.
Avillion LLP, a co-developer of late-stage pharmaceutical assets, announces the completion of enrolment in a global Phase III clinical trial called "BFORE," which is designed to assess the effectiveness and safety of BOSULIF (bosutinib) as a first-line treatment for patients with chronic phase Philadelphia chromosome positive (Ph+) chronic myelogenous leukemia (CML).
Digitalization is moving forward fast in every field, including medicine. But how can digital tools be integrated into healthcare processes, and how should data be visualized to personalize patient care?
Quest Diagnostics, the world's leading provider of diagnostic information services, today announced that it has signed a definitive agreement to sell its HemoCue diagnostic products business to Radiometer Medical ApS for a purchase price of approximately $300 million plus customary adjustments for cash balances.
› Verified 8 days ago
| Entity Name | Hackensack Cardiology Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619498540 PECOS PAC ID: 7416228960 Enrollment ID: O20170802002055 |
News Archive
Advances in medical technology are a main factor driving the trend of increasing health care costs, and industry stakeholders agree that improved evaluation methods are needed to better measure the benefits and risks of new technologies and procedures in order to avoid misallocation of health care dollars.
Starpharma today announced that it has received final written agreement from the FDA on the design of its Phase 3 clinical studies of VivaGel® for the treatment of bacterial vaginosis (BV) under the FDA's Special Protocol Assessment (SPA) scheme.
Avillion LLP, a co-developer of late-stage pharmaceutical assets, announces the completion of enrolment in a global Phase III clinical trial called "BFORE," which is designed to assess the effectiveness and safety of BOSULIF (bosutinib) as a first-line treatment for patients with chronic phase Philadelphia chromosome positive (Ph+) chronic myelogenous leukemia (CML).
Digitalization is moving forward fast in every field, including medicine. But how can digital tools be integrated into healthcare processes, and how should data be visualized to personalize patient care?
Quest Diagnostics, the world's leading provider of diagnostic information services, today announced that it has signed a definitive agreement to sell its HemoCue diagnostic products business to Radiometer Medical ApS for a purchase price of approximately $300 million plus customary adjustments for cash balances.
› Verified 8 days ago
| Entity Name | Icahn School Of Medicine At Mount Sinai |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922638097 PECOS PAC ID: 2062838469 Enrollment ID: O20200805001588 |
News Archive
Advances in medical technology are a main factor driving the trend of increasing health care costs, and industry stakeholders agree that improved evaluation methods are needed to better measure the benefits and risks of new technologies and procedures in order to avoid misallocation of health care dollars.
Starpharma today announced that it has received final written agreement from the FDA on the design of its Phase 3 clinical studies of VivaGel® for the treatment of bacterial vaginosis (BV) under the FDA's Special Protocol Assessment (SPA) scheme.
Avillion LLP, a co-developer of late-stage pharmaceutical assets, announces the completion of enrolment in a global Phase III clinical trial called "BFORE," which is designed to assess the effectiveness and safety of BOSULIF (bosutinib) as a first-line treatment for patients with chronic phase Philadelphia chromosome positive (Ph+) chronic myelogenous leukemia (CML).
Digitalization is moving forward fast in every field, including medicine. But how can digital tools be integrated into healthcare processes, and how should data be visualized to personalize patient care?
Quest Diagnostics, the world's leading provider of diagnostic information services, today announced that it has signed a definitive agreement to sell its HemoCue diagnostic products business to Radiometer Medical ApS for a purchase price of approximately $300 million plus customary adjustments for cash balances.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Irfan Admani, 103 River Road, Edgewater, NJ 07020 Ph: (201) 941-8100 | Irfan Admani, 103 River Road, Edgewater, NJ 07020 Ph: (201) 941-8100 |
News Archive
Advances in medical technology are a main factor driving the trend of increasing health care costs, and industry stakeholders agree that improved evaluation methods are needed to better measure the benefits and risks of new technologies and procedures in order to avoid misallocation of health care dollars.
Starpharma today announced that it has received final written agreement from the FDA on the design of its Phase 3 clinical studies of VivaGel® for the treatment of bacterial vaginosis (BV) under the FDA's Special Protocol Assessment (SPA) scheme.
Avillion LLP, a co-developer of late-stage pharmaceutical assets, announces the completion of enrolment in a global Phase III clinical trial called "BFORE," which is designed to assess the effectiveness and safety of BOSULIF (bosutinib) as a first-line treatment for patients with chronic phase Philadelphia chromosome positive (Ph+) chronic myelogenous leukemia (CML).
Digitalization is moving forward fast in every field, including medicine. But how can digital tools be integrated into healthcare processes, and how should data be visualized to personalize patient care?
Quest Diagnostics, the world's leading provider of diagnostic information services, today announced that it has signed a definitive agreement to sell its HemoCue diagnostic products business to Radiometer Medical ApS for a purchase price of approximately $300 million plus customary adjustments for cash balances.
› Verified 8 days ago
Mr. Andrei Terentiev, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 103 River Rd, Edgewater, NJ 07020 Phone: 201-945-4288 Fax: 201-945-8690 | |
Dr. Fernando Segovia, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 103 River Rd, Edgewater, NJ 07020 Phone: 201-941-8100 Fax: 201-941-2899 | |
Sameera Daud-ahmad, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 725 River Rd Ste 106, Edgewater, NJ 07020 Phone: 201-781-5850 Fax: 201-781-5850 | |
Dr. Mohammed Ali Jaloudi, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 104 Adams Ct, Edgewater, NJ 07020 Phone: 201-888-3853 | |
Dr. Yaron Bareket, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 103 River Rd, Edgewater, NJ 07020 Phone: 201-941-8100 Fax: 201-941-2899 | |
Lucia Alvarez, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 103 River Rd Fl 2, Edgewater, NJ 07020 Phone: 201-941-9952 |